AmboVent

CoronaTech 1nn0v8tion Headquarters - Israel

AmboVent Contact Solution Provider

Solution Overview & Benefits

Information updated: April 27th 2020

This is an augmented AmbuBag device.

Designed as an alternative automatic, controlled, and ventilation system for adults, to be used online in emergency situations when no other ventilation systems are available.

Summary Specs:

  • Volume control ventilation (VCV) machine.
  • Campaitible with Ambu (and other) self-inflating bags.
  • Wide options of tidal volume selection ranging from 30% - 100% of full squeezing capacity.
  • 11 ventilation rates ranging from 6 - 24 cycles per minute.
  • Maximum inhilation pressure settings, ranging between 30-70 cmH2O, increasing by steps of 10.
  • Capable of choosing Peak Inspiratory Pressure (PIP) sensing threshold, ranging between 30-70 cmH2O
  • Standard 110/220 V Powerline feed + 2 hour battery backup.
  • Ventilation pressure continuous monitoring
  • Works with standard Positive End-Expiratory Pressure (PEEP) Valves.
  • Alarms and Display compatible with UK Rapidly Manufactured Ventilator System minimal requirements.

(more details can be found on the project websites - see links below)

History & Development

AmboVent, an open-source automatically controlled medical ventilator device, was designed by a team of Israeli engineers and medical experts as a response to the worldwide shortages in mechanical ventilation devices due to the COVID-19 respiratory disease epidemic outbreak caused by Coronavirus.

The AmboVent respirator was engineered for mass-production at low costs, using off-the-shelf components removing the need for intricate assembly lines. The device's entire blueprints, mechanical & electrical designs, source-codes, and medical/engineering test reports were published on GitHub as open-source hardware and software on the evening of 1 April 2020.

Team Disclaimer:
This product is currently undergoing clinical trials. It has been tested in laboratory conditions. This product has not been cleared for clinical use yet in the state of Israel or elsewhere. Further testing is required to validate the effectiveness and safety of the product.

THIS DEVICE IS NOT APPROVED FOR CLINICAL USE YET.

Availability

Publicly available: No
Offered or can be licensed for local manufacture: Yes
Countries where available: AmboVent 1690.108 is currently being tested by the Israeli Regulatory Authority.

Additional Information

Solution Providers Website (external link)

Updates

If you are aware of any updates to the AmboVent project please complete the form or send an email to [email protected]

Need help finding solutions that respond to your unique development challenges? Apply through our Project Accelerator service or Contact us directly for needs-based project consulting.